Nicely written article, Antonio. You explain these complex concepts very succinctly. In your opinion, are current bioinformatics platforms robust enough to make a real impact in medicine? I.e. can we use these systems for specific tasks (e.g. screening a patient for a cancer gene) or is the current state of the art capable of more?